Laboratory-acquired infections

Clinical Infectious Diseases

Volumn 49, Issue 1, 2009, Pages 142-147

  Singh, Kamaljit ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; RIFAMPICIN;

ANTHRAX; BACILLUS ANTHRACIS; BACTERIAL INFECTION; BIOLOGICAL WARFARE; BRUCELLA; BRUCELLOSIS; FRANCISELLA TULARENSIS; HUMAN; INFECTION PREVENTION; INFECTION RISK; LABORATORY INFECTION; MENINGOCOCCOSIS; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; NEISSERIA MENINGITIDIS; OCCUPATIONAL HAZARD; PARASITOSIS; PRIORITY JOURNAL; REVIEW; SALMONELLA; SHIGELLA; TULAREMIA; VIRUS INFECTION;

CHEMOPREVENTION; HEALTH PERSONNEL; HUMANS; INFECTION; INFECTION CONTROL; LABORATORIES; OCCUPATIONAL EXPOSURE;

EID: 66949123803     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/599104     Document Type: Review

References (45)

1. Sewell DL. Laboratory associated infections and biosafety. Clin Microbiol Rev 1995; 8:389-405.
2. Lim PL, Kurup A, Gopalakrishna G, et al. Laboratory-acquired severe acute respiratory syndrome. N Engl J Med 2004;350:1740-5.
3. Pike RM. Laboratory-associated infections: summary and analysis of 3921 cases. Health Lab Sci 1976; 13:105-14.
4. Pike RM. Past and present hazards of working with infectious agents. Arch Pathol Lab Med 1978; 102:333-6.
5. Pike RM. Laboratory-associated infections: incidence, fatalities, causes and prevention. Annu Rev Microbiol 1979; 33:41-66.
6. Pike RM, Sulkin SE, Schulze ML. Continuing importance oflaboratory- acquired infections. Am J Public Health Nations Health 1965; 55:190-9.
7. Harrington JM, Shannon HS. Incidence of tuberculosis, hepatitis, brucellosis and shigellosis in British medical laboratory workers. Br Med J 1976; 1:759-62.
8. Grist NR, Emslie JAN. Infections in British clinical laboratories, 1988-1989. J Clin Pathol 1991;44:667-9.
9. Walker D, Campbell D. A survey of infections in United Kingdom laboratories, 1994-1995. J Clin Pathol 1999;52:415-8.
10. Jacobson JT, Orlob RB, Clayton JL. Infections acquired in clinical laboratories in Utah. J Clin Microbiol 1985; 21:486-9.
11. Baron E J, Miller M. Bacterial and fungal infections among diagnostic laboratory workers: evaluating the risks. Diagn Microbiol Infect Dis 2008; 60:241-6.
12. Kimman TG, Smit E, Klein MR. Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures. Clin Microbiol Rev 2008;21:403-25.
13. Robichaud S, Libmen M, Behr M, Rubin E. Prevention of laboratory- acquired brucellosis. Clin Infect Dis 2004; 38:e119-22.
14. Ergonul O, Celikbas A, Tezeren D, Guvener E, Dokuzoguz B. Analysis of risk factors for laboratory-acquired brucella infections. J Hosp Infect 2004; 56:223-7.
15. Centers for Disease Control and Prevention. Laboratory-acquired brucellosis-Indiana and Minnesota, 2006. MMWR Morb Mortal Wkly Rep 2008; 57:39-42.
16. Bouza E, Sanchez-Carillo C, Hernangomez S, Gonzalez MJ; The Spanish Co-operative Group for the Study of Laboratory-acquired Brucellosis. Laboratory-acquired brucellosis: a Spanish national survey. J Hosp Infect 2005;61:80-3.
17. Noviello S, Gallo R, Kelly M, et al. Laboratory-acquired brucellosis. Emerg Infect Dis 2004; 10:1848-50.
18. Fiori PL, Mastrandrea S, Rappelli P, Cappuccinelli P. Brucella abortus infection acquired in microbiology laboratories. J Clin Microbiol 2000; 38:2005-6.
19. Yagupsky P, Peled N, Riesenberg K, Banai M. Exposure of hospital personnel to Brucella melitensis and occurrence of laboratory-acquired disease in an endemic area. Scand J Infect Dis 2000; 32:31-5.
20. Harding AL, Byers KB. Epidemiology of laboratory-associated infections. In: Fleming DO, Hunt DL, eds. Biological safety: principles and practices. 3rd ed. Washington, DC: ASM Press, 2000:35-54.
21. Meyer KF, Eddie B. Laboratory infections due to Brucella. J Infect Dis 1941; 68:24-32.
22. Reuben B, Band JD, Wong P, Colville J. Person-to-person transmission of Brucella melitensis. Lancet 1991 ; 337:14-5.
23. Khan MY, Mah MW, Memish ZA. Brucellosis in pregnant women. Clin Infect Dis 2001;32:1172.
24. Sejvar JJ, Johnson D, Popovich T, et al. Assessing the risk of laboratory- acquired meningococcal disease. J Clin Microbiol 2005; 43:4811-4.
25. Centers for Disease Control and Prevention. Laboratory-acquired me- ningococcal disease-United States 2000. MMWR Morb Mortal Wkly Rep 2002;51:141-4.
26. Centers for Disease Control and Prevention. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2005;54(7):1-21.
27. Reid DD. Incidence of tuberculosis among workers in medical laboratories. Br Med J 1957;2:10-4.
28. Centers for Disease Control and Prevention and National Institutes of Health. Biosafety in microbiological and biomedical laboratories. 4th ed. Washington, DC: US Government Printing Office, 1999.
29. Pfyffer GE. Mycobacterium: general characteristics. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, eds. Manual ofclinical microbiology. 9th ed. Washington, DC: American Society of Microbiology, 2007.
30. Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon: medical and public health management. JAMA 2001 ;285:2763-73.
31. Shapiro DS, Schwartz DR. Exposure of laboratory workers to F. tu- larensis despite a bioterrorism procedure. J Clin Microbiol 2002;40:2278-81.
32. Meselson M, Guillemin J, Hugh-Jones M, et al. The Sverdlovsk anthrax outbreak of 1979. Science 1994; 266:1202.
33. Centers for Disease Control and Prevention. Suspected cutaneous anthrax in a laboratory worker-Texas, 2002. MMWR Morb Mortal Wkly Rep 2002;51:279-81.
34. Blaser MJ, Lofgren JP. Fatal salmonellosis originating in a clinical microbiology laboratory. J Clin Microbiol 1981 ; 13:855-8.
35. Blaser MJ, Feldman R. Acquisition of typhoid fever from proficiency testing specimens. N Engl J Med 1980; 303:1481.
36. Holmes MB, Johnson DL, Fiumara NJ, McCormack WM. Acquisition of typhoid fever from proficiency testing specimens. N Engl J Med 1980;303:519-21.
37. Coia JE. Nosocomial and laboratory-acquired infection with Escherichia coli O157. J Hosp Infect 1998;40:107-13.
38. Siegert R, Shu HL, Sleneczka W, et al. Zur atiologie einer unbekanten, von affen ausgegangen menschlichen Infektionskrankheit. Deutsch Med Wochenschr 1967;92:2341-3.
39. West DL. The risk of hepatitis B infection among health care professionals in the United States: a review. Am J Med Sci 1984; 287:26-33.
40. Centers for Disease Control and Prevention. Surveillance for acute viral hepatitis-United States, 2006. MMWR Morb Mortal Wkly Rep 2008; 57:1-24.
41. Bell DM. Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview. Am J Med 1997; 102(Suppl 5B):9-15.
42. Ippolito G, Puro V, De Carli G; Italian Study Group on Occupational Risk of HIV Infection. The risk of occupational human immunodeficiency virus in health care workers. Arch Intern Med 1993; 153:1451-8.
43. Centers for Disease Control and Prevention. Surveillance for occupationally acquired HIV infection-United States, 1981-1992. MMWR Morb Mortal Wkly Rep 1992;41:823-5.
44. Centers for Disease Control and Prevention. Updated US Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR Morb Mortal Wkly Rep 2005;54:1-17.
45. Herwaldt BL. Laboratory-acquired parasitic infections form accidental exposures. Clin Microbiol Rev 2001 ; 14:659-88.